Making the FDA Great Again
• The US Food and Drug Administration (FDA) is experiencing a period of instability characterized by the loss of thousands of employees through terminations or resignations. • The agency's accumulated expertise has been eroded, particularly within the drug and biologics centers, including the Center for Biologics Evaluation and Research. • This turmoil is attributed to politically appointed leadership, including Vinay Prasad, who have departed from the agency's traditional scientific norms for medical product reviews.
aei.org

